Register
Login:
Share:
Email Facebook Twitter


London South East Natural Resources Briefing webcast: #Emmerson #Alba #Condor Gold #Gold analysis
Angus Energy in talks to buy 'transformational' gas asset in North England




Share Price Information for Summit Ther (SUMM)


Share Price: 26.00Bid: 25.00Ask: 27.00Change: -2.00 (-7.14%)Faller - Summit Ther
Spread: 2.00Spread as %: 8.00%Open: 26.50High: 26.50Low: 26.00Yesterday’s Close: 28.00

Summit Therapeutics Plc Ord 1P

Summit Ther is listed in the FTSE AIM All-Share
Summit Ther is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
26.00
Share Price SpacerBid
25.00
Share Price SpacerAsk
27.00
Share Price SpacerChange
-7.14%-2.00
Share Price SpacerVolume
115,668
Share Price SpacerOpen
26.50
Share Price SpacerHigh
26.50
Share Price SpacerLow
26.00
Share Price SpacerClose
28.00
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 160.49m £41.73m 3,000

52 Week High 200.00 52 Week High Date 26-JUN-2018
52 Week Low 17.00 52 Week Low Date 14-DEC-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
11 111,455 4,213 2.889 9.00 0.00 0.00


London South East Users info for Summit Ther




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

23-May-19
15:11:20
25.55
1,500
Sell* 
25.00
27.00
383.25
Trade Type:
Ordinary

23-May-19
14:20:15
25.55
3,000
Sell* 
25.00
27.00
766.50
Trade Type:
Ordinary

23-May-19
13:44:55
25.51
21,881
Sell* 
25.00
27.00
5,582
Trade Type:
Ordinary




View more Summit Ther trades >>

Directors Deals for Summit Ther (SUMM)
Trade DateActionNotifierPriceCurrencyAmountHolding
23-Apr-19Transfer From
Trade Notifier Information for Summit Therapeutics
Frank Armstrong held the position of Non-Executive Chairman at Summit Therapeutics at the time of this trade.
 Frank Armstrong
036,585158789
23-Apr-19Transfer From
Trade Notifier Information for Summit Therapeutics
Valerie Andrews held the position of Non-Executive Director at Summit Therapeutics at the time of this trade.
 Valerie Andrews
017,07366196
23-Apr-19Transfer From
Trade Notifier Information for Summit Therapeutics
David Wurzer held the position of Non-Executive Director at Summit Therapeutics at the time of this trade.
 David Wurzer
017,07363196
View more Summit Ther directors dealings >>


stew200
Posts: 11,203
Opinion:No Opinion
Price:26.50
Chris
Sun 21:50
Thanks! Could well gain traction soon here
Chrisatrdg
Posts: 1,498
Opinion:Strong Buy
Price:26.50
RE: Article on C-Diff great mention of
Sun 18:35
Hi stew200 - I do not think that we will see a great rush to Buy on Monday but momentum is building but you never know.
stew200
Posts: 11,203
Opinion:No Opinion
Price:26.50
Article on C-Diff great mention of
Sun 17:17
What do you think the share price will do next week?
Chrisatrdg
Posts: 1,498
Opinion:Strong Buy
Price:26.50
Article on C-Diff great mention of ..
Sun 12:02
Per Bermudashorts from the other board:

Nice mention for Ridinilazole here:-
'But there is an answer. In fact, two. One is a drug called Fidaxomicin – very expensive and definitely not government subsidized. The other, the one in which researchers including Riley hold great hope, is a new drug Ridinilazole.
Ridinilazole is now in Phase-3 clinical trials and is expected to become available in about two years.'

https://cosmosmagazine.com/biology/the-looming-threat-of-c-diff
Chrisatrdg
Posts: 1,498
Opinion:Strong Buy
Price:26.50
RNS Today
14 May '19
RNS Out this evening
Annual Report & Accounts Y/E 31st January 2019 (AGM 19th June)
https://www.summitplc.com/app/uploads/2019/05/2019_Summit-Therapeutics-AR.pdf
View more share chat for Summit Ther (SUMM) >>







Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk











Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.